Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2019) [Effective from January 1, 2019]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2017: 100.00
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2017: 100.00
NAAS RATING 2018: 5.38

Int.J.Curr.Microbiol.App.Sci.2018.7(10): 1312-1320
DOI: https://doi.org/10.20546/ijcmas.2018.710.147


Prevalence of HCV Antibodies in Chronic Liver Disease Patients in Tertiary Care Hospital
Aliya Fatima and K. Nagamani
Department of Microbiology, Gandhi Medical College & Hospital, Secunderabad, Telangana, India
*Corresponding author
Abstract:

Viral infections account for significant proportion of CLD. Hepatitis C virus is the major cause of non-A, non-B hepatitis worldwide. HCV can lead to chronic liver disease causing cirrhosis, hepatocellular carcinoma and end stage liver disease among 5-20% of infected persons. In India about 20 million people are known to have HCV infection and a quarter of them are expected to develop chronic liver disease in the next 10-15 years. 1) To determine prevalence of Hepatitis C virus infection in chronic liver disease patients. 2) To identify the risk factor for HCV infection. A total of 100 Cases of CLD attending Gastroenterology department were included in the study during the period of January 2015 – June 2016. Demographic data and clinical findings were recorded using a structured proforma. All the samples were screened for anti HCV antibodies by ELISA (HCV MICROLISA) according to the kit manufacturer’s instructions. Out of 100 CLD Patients, 81(81%) were Males and 19(19%) were Females. HCV antibodies were found positive in 4 cases. Out of 4 cases, 3 were Males and 1 was Female. Prevalence of HCV in CLD Patients was 4%. The major risk factor for HCV Infection was Surgery.


Keywords: CLD, HCV
Download this article as Download

How to cite this article:

Aliya Fatima and Nagamani, K. 2018. Prevalence of HCV Antibodies in Chronic Liver Disease Patients in Tertiary Care Hospital.Int.J.Curr.Microbiol.App.Sci. 7(10): 1312-1320. doi: https://doi.org/10.20546/ijcmas.2018.710.147